ATOS
Atossa Genetics
Atossa Genetics NASDAQ: ATOS is a Seattle-based healthcare firm that specializes in breast health. The company focuses on the development and marketing of pharmaceuticals for the treatment of breast conditions, including breast cancer.The company is named after the Persian Queen Atossa, who became the first woman in recorded history with breast cancer around 470 B.C.
Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 25.88M; Volume: 42.00K; AvgVol 3m: 685.10K; Beta: 2.28;
Cost estimate:
P/E: –; EPS: -1.39; EPS growth quarter/prev quarter: 46.60%;
EPS growth this year: 63.10%; EPS growth past 5 years: 53.30%;
EPS ttm: -1.39;
P/S: ; P/B: 2.69; P/Cashflow: 3.18; P/FCF: ;
Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;
Profitability:
Gross Margin: ; Profit Margin: ; Operating Margin: ;
ROA – return on assets: -96.10%; ROE – return on equity: -113.90%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 0.57%; Insider Transactions:0.00%;
Institutional Ownership: 2.90%; Institutional Transactions: 22.92%;
Data update: 07/10/2020.